Shots:
Viatris has signed definitive agreements to sell its Biocon Biologics stake to Biocon for ~$815M
Under the agreements, Viatris will sell its Biocon Biologics stake to Biocon for $400M in cash and $415M in Biocon shares, to be listed on NSE with a six-month lock-up. As part of the agreement, the biosimilar non-compete restrictions…
